Journal of Virology, March 2001, p. 2033-2040, Vol. 75, No. 5
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.5.2033-2040.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Institute for Clinical Molecular Biology and Tumor Genetics, GSF National Research Center of Environment and Health, D-81377 Munich, Germany
Received 24 August 2000/Accepted 1 December 2000
Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) and latent
membrane protein 1 (LMP1) are essential for immortalization of human B
cells by EBV. EBNA2 and activated Notch transactivate genes by
interacting with the cellular transcription factor RBP-J
/CBF1. Therefore, EBNA2 can be regarded as a functional homologue of activated
Notch. We have shown previously that the intracellular domain of Notch1
(Notch1-IC) is able to transactivate EBNA2-regulated viral promoters
and to induce phenotypic changes in B cells similar to those caused by
EBNA2. Here we investigated whether Notch1-IC can substitute for EBNA2
in the maintenance of B-cell proliferation. Using an EBV-immortalized
lymphoblastoid cell line in which EBNA2 function can be regulated by
estrogen, we demonstrate that murine Notch1-IC, in the absence of
functional EBNA2, is unable to maintain LMP1 expression and to maintain
cell proliferation. However, in a lymphoblastoid cell line expressing
LMP1 independently of EBNA2, murine Notch1-IC can transiently maintain
proliferation after EBNA2 inactivation. After 4 days, cell numbers do
not increase further, and cells in the G2 phase of the cell
cycle start to die. In contrast to EBNA2, murine Notch1-IC is unable to
upregulate the expression of the c-myc gene in these cells.
Present address: Institute for Genetics, University of Cologne,
D-50931 Cologne, Germany.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|